Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Post by 48thHighlanderon Jul 12, 2018 11:47am
96 Views
Post# 28306448

Which Do You Prefer...?..M or A ..?

Which Do You Prefer...?..M or A ..?If it walks, talks and acts like a money maker....it will be vacuumed up !


https://www.bloomberg.com/view/articles/2018-06-19/roche-s-foundation-medicine-purchase-is-smart-use-of-buying-power

For instance, Roche paid $1.7 billion earlier this year to buy Ignyta Inc., which is developing a drug that isn’t targeted to a tumor in a particular part of the body, but to a specific (and rare) genetic mutation that can occur in multiple types of cancer. This is a novel concept in cancer treatment, and finding those patients is going to be difficult.
<< Previous
Bullboard Posts
Next >>